Herbert Barthlow
AstraZeneca (South Korea)(KR)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Neuropeptides and Animal Physiology, Pulmonary Hypertension Research and Treatments, Receptor Mechanisms and Signaling, Neuroscience of respiration and sleep
Most-Cited Works
- → Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pKa: Antibacterial Agents with an Improved Safety Profile(2012)89 cited
- → Vagal innervation of guinea pig bronchial smooth muscle(1990)84 cited
- → A high-throughput in vitro ring assay for vasoactivity using magnetic 3D bioprinting(2016)67 cited
- → Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster.(1993)56 cited
- → Design, Synthesis, and SAR of Tachykinin Antagonists: Modulation of Balance in NK1/NK2 Receptor Antagonist Activity(2002)51 cited
- → Discovery of novel, orally active dual NK1/NK2 antagonists(2001)39 cited
- → Assessment of cisplatin-induced kidney injury using an integrated rodent platform(2013)32 cited
- → Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors(2001)30 cited
- → Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa(2014)24 cited
- → Hypoxic exposure time dependently modulates endothelininduced contraction of pulmonary artery smooth muscle(1998)23 cited